WHO ICTRP trial
A dynamic, multiple-biomarker approach aiming for individualized treatment of…
NL-OMON51533 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON51533 |
|---|---|
| Public title | A dynamic, multiple-biomarker approach aiming for individualized treatment of heart failure with preserved ejection fraction |
| Scientific title | A dynamic, multiple-biomarker approach aiming for individualized treatment of heart failure with preserved ejection fraction - ADAPT-HFpEF |
| Primary sponsor | Universitair Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | Heart failure; HFpEF;10019280;Heart failure; HFpEF |
| Interventions | ;Biomarkers;Heart failure;HFpEF;Repeated measurements |
| Registration date | Sep 2, 2022 |
| Target size | 200 |
| Secondary IDs | NL80596.078.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: